Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets
Year: 2017
Type: article
Abstract: The plasma protein von Willebrand factor (VWF) is essential for hemostasis initiation at sites of vascular injury. The platelet-binding A1 domain of VWF is connected to the VWF N-terminally located D′D3 domain through a relatively unstructured amino acid sequence, called here the N-terminal linker. This region has previously been shown to inhibit the binding of VWF to the platelet surface receptor glycoprotein Ibα (GpIbα). However, the molecular mechanism underlying the inhibitory function of the N-terminal linker has not been elucidated. Here, we show that an aspartate at position 1261 is the most critical residue of the N-terminal linker for inhibiting binding of the VWF A1 domain to GpIbα on platelets in blood flow. Through a combination of molecular dynamics simulations, mutagenesis, and A1–GpIbα binding experiments, we identified a network of salt bridges between Asp 1261 and the rest of A1 that lock the N-terminal linker in place such that it reduces binding to GpIbα. Mutations aimed at disrupting any of these salt bridges activated binding unless the mutated residue also formed a salt bridge with GpIbα, in which case the mutations inhibited the binding. These results show that interactions between charged amino acid residues are important both to directly stabilize the A1–GpIbα complex and to indirectly destabilize the complex through the N-terminal linker.
Source: Journal of Biological Chemistry
Authors: Gianluca Interlandi, Olga Yakovenko, An-Yue Tu, Jeff Harris, Jennie Le, Junmei Chen, José A. López, Wendy E. Thomas
Institutions: University of Washington, Bloodworks Northwest
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Awards: Structural analysis of oxidation effects on the hemostatic process, von Willebrand Factor in Sickle Cell Disease Pathophysiology, Biosynthetic and Functional Consequences of von Willebrand Disease Mutations, Regulation of von Willebrand Factor - platelet binding by Force and Interdomain I, Endothelial Activation and Microangiopathy in HIV-related Cardiovascular Disease
OpenAlex ID: W2754464547
